Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Preliminary Assessment of a Microwave System to Detect Contrast Enhancing Agents.

Rahman M, Ahsan S, Lahri R, Thanou M, Kosmas P.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:937-940. doi: 10.1109/EMBC.2018.8512313.

PMID:
30440544
2.

Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.

Vllasaliu D, Thanou M, Stolnik S, Fowler R.

Expert Opin Drug Deliv. 2018 Aug;15(8):759-770. doi: 10.1080/17425247.2018.1504017. Epub 2018 Jul 27. Review.

PMID:
30033780
3.

Zinc oxide nanoparticles as contrast-enhancing agents for microwave imaging.

Lahri R, Rahman M, Wright M, Kosmas P, Thanou M.

Med Phys. 2018 Jun 25. doi: 10.1002/mp.13062. [Epub ahead of print]

PMID:
29939399
4.

Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.

Centelles MN, Wright M, So PW, Amrahli M, Xu XY, Stebbing J, Miller AD, Gedroyc W, Thanou M.

J Control Release. 2018 Jun 28;280:87-98. doi: 10.1016/j.jconrel.2018.04.047. Epub 2018 May 1.

PMID:
29723616
5.

Denosumab for the treatment of adult multisystem Langerhans cell histiocytosis.

Makras P, Tsoli M, Anastasilakis AD, Thanou M, Kaltsas G.

Metabolism. 2017 Apr;69:107-111. doi: 10.1016/j.metabol.2017.01.004. Epub 2017 Jan 12.

PMID:
28285639
6.

Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity.

Monnery BD, Wright M, Cavill R, Hoogenboom R, Shaunak S, Steinke JHG, Thanou M.

Int J Pharm. 2017 Apr 15;521(1-2):249-258. doi: 10.1016/j.ijpharm.2017.02.048. Epub 2017 Feb 21.

PMID:
28232268
7.

Focused ultrasound induced hyperthermia accelerates and increases the uptake of anti-HER-2 antibodies in a xenograft model.

Centelles MN, Wright M, Gedroyc W, Thanou M.

Pharmacol Res. 2016 Dec;114:144-151. doi: 10.1016/j.phrs.2016.10.017. Epub 2016 Oct 19.

PMID:
27771465
8.

Hydrophobin-Encapsulated Quantum Dots.

Taniguchi S, Sandiford L, Cooper M, Rosca EV, Ahmad Khanbeigi R, Fairclough SM, Thanou M, Dailey LA, Wohlleben W, von Vacano B, de Rosales RT, Dobson PJ, Owen DM, Green M.

ACS Appl Mater Interfaces. 2016 Feb;8(7):4887-93. doi: 10.1021/acsami.5b11354. Epub 2016 Feb 10.

PMID:
26824334
9.

Thermosensitive, near-infrared-labeled nanoparticles for topotecan delivery to tumors.

Rosca EV, Wright M, Gonitel R, Gedroyc W, Miller AD, Thanou M.

Mol Pharm. 2015 May 4;12(5):1335-46. doi: 10.1021/mp5002679. Epub 2015 Apr 20.

PMID:
25826624
10.

Optical nanoparticles: general discussion.

Dobson P, Yung LL, Rossi L, Pikramenou Z, Carreira S, Ray P, Amiens C, Brown K, Abdollah M, Zhou D, Prato M, Moise S, Litti L, Todd M, Göeken K, Borsley S, Heuer-Jungemann A, Reiser O, Harvey P, Carter T, Thanou M, Soukup D, Lesniak A, Mattoussi H, Abdul Ghani SF.

Faraday Discuss. 2014;175:215-27. doi: 10.1039/C4FD90079K. No abstract available.

11.

Magnetic nanoparticles: general discussion.

Dobson P, Yung LL, Rossi L, Carreira S, Ray P, Amiens C, Brown K, Zhou D, Gavriilidis A, Thanh NT, Moise S, Litti L, Mattoussi H, Todd M, Mitchell S, Borsley S, Heuer-Jungemann A, Reiser O, Tsang E, Thanou M, Berkleman T, Soukup D, Chester K, Parkin I, Diaz Fernandez YA, Burke BP.

Faraday Discuss. 2014;175:113-35. doi: 10.1039/C4FD90078B. No abstract available.

12.

Other nanoparticles: general discussion.

Pikramenou Z, McCallion C, Carreira S, Dobson P, Brown K, Diaz Fernandez YA, Abdollah M, Zhou D, Sun D, Moise S, Litti L, Yung LL, Borsley S, Dragneva N, Barchanski A, El-Sayed M, Heuer-Jungemann A, Pallares RM, Tsang E, Barry N, Mitchell S, Thanh NT, Thanou M, Parkin I, Ray P, Jones R.

Faraday Discuss. 2014;175:289-303. doi: 10.1039/C4FD90077D. No abstract available.

13.

Three bisphosphonate ligands improve the water solubility of quantum dots.

Abdul Ghani SF, Wright M, Paramo JG, Bottrill M, Green M, Long N, Thanou M.

Faraday Discuss. 2014;175:153-69. doi: 10.1039/c4fd00151f.

PMID:
25318058
14.

Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging.

Hashim Z, Green M, Chung PH, Suhling K, Protti A, Phinikaridou A, Botnar R, Khanbeigi RA, Thanou M, Dailey LA, Commander NJ, Rowland C, Scott J, Jenner D.

Nanoscale. 2014 Jul 21;6(14):8376-86. doi: 10.1039/c4nr01491j.

PMID:
24941427
15.

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.

Xu Y, Zhang H, Lit LC, Grothey A, Athanasiadou M, Kiritsi M, Lombardo Y, Frampton AE, Green AR, Ellis IO, Ali S, Lenz HJ, Thanou M, Stebbing J, Giamas G.

Sci Signal. 2014 Jun 17;7(330):ra58. doi: 10.1126/scisignal.2005170.

PMID:
24939894
16.

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA.

Yingyuad P, Mével M, Prata C, Kontogiorgis C, Thanou M, Miller AD.

J RNAi Gene Silencing. 2014 Jan 28;10:490-9. eCollection 2014.

17.

Spontaneous Retroperitoneal Hemorrhage (Wunderlich Syndrome) due to Large Upper Pole Renal Angiomyolipoma: Does Robotic-Assisted Laparoscopic Partial Nephrectomy Have a Role in Primary Treatment?

Ploumidis A, Katafigiotis I, Thanou M, Bodozoglou N, Athanasiou L, Ploumidis A.

Case Rep Urol. 2013;2013:498694. doi: 10.1155/2013/498694. Epub 2013 Sep 11.

18.

Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles.

Wang M, Miller AD, Thanou M.

J Drug Target. 2013 Aug;21(7):684-92. doi: 10.3109/1061186X.2013.805336. Epub 2013 Jun 18.

PMID:
23773028
19.

MRI-Guided Focused Ultrasound as a New Method of Drug Delivery.

Thanou M, Gedroyc W.

J Drug Deliv. 2013;2013:616197. doi: 10.1155/2013/616197. Epub 2013 May 12.

20.

Examination of the effect of increasing the number of intra-disulfide amino functional groups on the performance of small molecule cyclic polyamine disulfide vectors.

Drake CR, Aissaoui A, Argyros O, Thanou M, Steinke JH, Miller AD.

J Control Release. 2013 Oct 10;171(1):81-90. doi: 10.1016/j.jconrel.2013.02.014. Epub 2013 Feb 26.

PMID:
23454113
21.

Enzyme-triggered PEGylated pDNA-nanoparticles for controlled release of pDNA in tumors.

Yingyuad P, Mével M, Prata C, Furegati S, Kontogiorgis C, Thanou M, Miller AD.

Bioconjug Chem. 2013 Mar 20;24(3):343-62. doi: 10.1021/bc300419g. Epub 2013 Feb 19.

PMID:
23305338
22.

pH-triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo.

Kolli S, Wong SP, Harbottle R, Johnston B, Thanou M, Miller AD.

Bioconjug Chem. 2013 Mar 20;24(3):314-32. doi: 10.1021/bc3004099. Epub 2013 Mar 7.

PMID:
23305315
23.

Biosynthesis of luminescent quantum dots in an earthworm.

Stürzenbaum SR, Höckner M, Panneerselvam A, Levitt J, Bouillard JS, Taniguchi S, Dailey LA, Ahmad Khanbeigi R, Rosca EV, Thanou M, Suhling K, Zayats AV, Green M.

Nat Nanotechnol. 2013 Jan;8(1):57-60. doi: 10.1038/nnano.2012.232. Epub 2012 Dec 23.

PMID:
23263722
24.

A rare case of postpartum thrombocytosis. Differential diagnosis and management.

Iavazzo C, Thanou M, Deligeoroglou E.

G Chir. 2012 Aug-Sep;33(8-9):268-70.

PMID:
23017286
25.

Post-coupling strategy enables true receptor-targeted nanoparticles.

Chen J, Jorgensen MR, Thanou M, Miller AD.

J RNAi Gene Silencing. 2011;7:449-55. Epub 2011 Sep 15.

26.

Bioresponsive small molecule polyamines as noncytotoxic alternative to polyethylenimine.

Drake CR, Aissaoui A, Argyros O, Serginson JM, Monnery BD, Thanou M, Steinke JH, Miller AD.

Mol Pharm. 2010 Dec 6;7(6):2040-55. doi: 10.1021/mp9002249. Epub 2010 Oct 7.

PMID:
20929266
27.

Targeting nanoparticles to cancer.

Wang M, Thanou M.

Pharmacol Res. 2010 Aug;62(2):90-9. doi: 10.1016/j.phrs.2010.03.005. Epub 2010 Apr 7. Review.

PMID:
20380880
28.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD.

J Control Release. 2010 Apr 19;143(2):222-32. doi: 10.1016/j.jconrel.2009.12.001. Epub 2009 Dec 5.

PMID:
19969034
29.

Biodegradation, biodistribution and toxicity of chitosan.

Kean T, Thanou M.

Adv Drug Deliv Rev. 2010 Jan 31;62(1):3-11. doi: 10.1016/j.addr.2009.09.004. Epub 2009 Oct 1. Review.

PMID:
19800377
30.

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.

Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD.

Bioconjug Chem. 2009 Apr;20(4):648-55. doi: 10.1021/bc8002259.

PMID:
19368341
31.

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

Carmona S, Jorgensen MR, Kolli S, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Miller AD.

Mol Pharm. 2009 May-Jun;6(3):706-17. doi: 10.1021/mp800157x.

PMID:
19159285
32.

Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.

Wang M, Löwik DW, Miller AD, Thanou M.

Bioconjug Chem. 2009 Jan;20(1):32-40. doi: 10.1021/bc8001908.

PMID:
19099499
33.

Enhanced fluid flow through nanoscale carbon pipes.

Whitby M, Cagnon L, Thanou M, Quirke N.

Nano Lett. 2008 Sep;8(9):2632-7. doi: 10.1021/nl080705f. Epub 2008 Aug 5. Erratum in: Nano Lett. 2009 Jul;9(7):2802.

PMID:
18680352
34.

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.

Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.

PMID:
18662762
35.

N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.

Thanou M, Henderson S, Kydonieus A, Elson C.

J Control Release. 2007 Feb 12;117(2):171-8. Epub 2006 Nov 11.

PMID:
17184870
36.

Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation.

Florea BI, Thanou M, Junginger HE, Borchard G.

J Control Release. 2006 Jan 10;110(2):353-361. doi: 10.1016/j.jconrel.2005.10.001. Epub 2005 Nov 2.

PMID:
16269199
37.

Voltammetric study of interaction between polymers (PEI and TMO) and pDNA on a hanging mercury drop electrode.

Gherghi ICh, Girousi ST, Thanou M, Voulgaropoulos AN, Tzimou-Tsitouridou R.

J Pharm Biomed Anal. 2005 Sep 1;39(1-2):177-80. Epub 2005 Apr 22.

PMID:
16085138
38.

Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.

Kean T, Roth S, Thanou M.

J Control Release. 2005 Apr 18;103(3):643-53.

PMID:
15820411
39.

Polymer-protein and polymer-drug conjugates in cancer therapy.

Thanou M, Duncan R.

Curr Opin Investig Drugs. 2003 Jun;4(6):701-9. Review. Erratum in: Curr Opin Investig Drugs. 2003 Oct;4(10):1250.

PMID:
12901229
40.

Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines.

Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G.

Biomaterials. 2002 Jan;23(1):153-9.

PMID:
11762833
41.

Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P.

Thanou M, Verhoef JC, Nihot MT, Verheijden JH, Junginger HE.

Pharm Res. 2001 Nov;18(11):1638-41. No abstract available.

PMID:
11758776
42.

Oral drug absorption enhancement by chitosan and its derivatives.

Thanou M, Verhoef JC, Junginger HE.

Adv Drug Deliv Rev. 2001 Nov 5;52(2):117-26. Review.

PMID:
11718935
43.

Chitosan and its derivatives as intestinal absorption enhancers.

Thanou M, Verhoef JC, Junginger HE.

Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S91-101. Review.

PMID:
11576697
44.

Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Thanou M, Verhoef JC, Verheijden JH, Junginger HE.

Pharm Res. 2001 Jun;18(6):823-8.

PMID:
11474787
47.

N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).

Thanou M, Florea BI, Langemeÿer MW, Verhoef JC, Junginger HE.

Pharm Res. 2000 Jan;17(1):27-31.

PMID:
10714604
48.

Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.

Thanou MM, Kotzé AF, Scharringhausen T, Luessen HL, de Boer AG, Verhoef JC, Junginger HE.

J Control Release. 2000 Feb 14;64(1-3):15-25.

PMID:
10640642
49.

Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea.

Thanou MM, Verhoef JC, Romeijn SG, Nagelkerke JF, Merkus FW, Junginger HE.

Int J Pharm. 1999 Aug 5;185(1):73-82.

PMID:
10425367
50.

Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

Kotzé AF, Thanou MM, Luessen HL, de Boer BG, Verhoef JC, Junginger HE.

Eur J Pharm Biopharm. 1999 May;47(3):269-74.

PMID:
10382111

Supplemental Content

Loading ...
Support Center